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Systemic sclerosis is a complex disease that involves “autoimmunity,” “inflammation,” “fibrosis,” and “vasculopathy.”
Microvascular damage and dysfunction particularly represent the earliest morphological and functional markers of
systemic sclerosis. These morphological changes and progressions can be detected by nailfold videocapillaroscopy
(NVC).
In 2013, the American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) proposed
a new set of criteria for systemic sclerosis for the first time in 30 years. Items are given a weighted score, and a
score more than 9 indicates systemic sclerosis. These classification criteria encompass a broader spectrum of
systemic sclerosis patients including those with early stage and with excellent sensitivity and specificity. Notably,
nailfold capillary abnormalities were one of the new items in the criteria. Moreover, these abnormalities are also
markers of systemic sclerosis severity and progression, as reduced capillary density has been associated with a high
risk of developing digital skin ulcers and pulmonary arterial hypertension. Since microvascular damage and
dysfunction represent early markers of systemic sclerosis, qualitative and semi-quantitative assessment of
videocapillaroscopy images is expected in clinical application and treatment outcome assessment.
Despite the potential for targeted therapies in systemic sclerosis, there is no established therapy as yet. This may be
due to several reasons. First, no fully validated outcome measures exist. Second, diagnosis of systemic sclerosis is
often delayed and early intervention is difficult. Moreover, systemic sclerosis has clinical heterogeneity. Appropriate
use of NVC helps to overcome these issues. Moreover, NVC may be useful in evaluating the pathogenesis of
systemic sclerosis.
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In 2013, the American College of Rheumatology and the
European League Against Rheumatism (ACR/EULAR)
collaborated to propose a new set of criteria for systemic
sclerosis for the first time in 30 years [1, 2]. These cri-
teria focused on the early diagnosis of systemic sclerosis.
Seven items, namely, skin thickening of the fingers,
fingertip lesions, telangiectasia, abnormal nailfold capil-
laries, pulmonary arterial hypertension and/or interstitial
lung disease, Raynaud’s phenomenon, and systemic
sclerosis-related autoantibodies, are given a weighted
score; a score more than 9 indicates systemic sclerosis.* Correspondence: kubosato@med.uoeh-u.ac.jp
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of systemic sclerosis patients including those with
early- and late-stage disease and with excellent sensi-
tivity and specificity. The most significant change in
these criteria was the inclusion of nailfold capillary
abnormalities as one of the new items. It is now
possible to diagnose systemic sclerosis with this
scoring system before skin thickening of the fingers is
detected.Role of NVC
Nailfold videocapillaroscopy (NVC) is the best and
safest method to detect and analyze morphological
microvascular abnormalities. NVC can detect normal
capillary morphology in healthy individuals or those
experiencing primary Raynaud phenomenon. However,article is distributed under the terms of the Creative Commons Attribution 4.0
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ity of secondary Raynaud phenomenon [3]. Specific
NVC changes known as the “systemic sclerosis pat-
tern” are typical of the microvascular involvement in
systemic sclerosis [4]. This review will summarize the
“systemic sclerosis pattern,” which is widely accepted
worldwide.
Normal capillary morphology
This section will address the normal morphology of
capillaries in healthy individuals [5]. Healthy subjects
have numerous thin and linear capillaries (Fig. 1).
Normal capillary morphology has several common
characteristics. First, the diameter of normal vessels is
less than 20 μm. However, it could be more than 20 μm
in some capillaries in healthy individuals. However, the
detection of even a single loop with a homogeneous in-
crease to a diameter more than 50 μm should be consid-
ered a potential marker of microangiopathy. Second,
capillaries are distributed with their major axis running
parallel to the skin surface. Finally, there are more than
9 capillaries within 1 mm of the row of the nailfold bed.
Abnormalities in these findings (fineness, direction, and
number of capillaries) are seen in patients with systemic
sclerosis. These sequential capillaroscopic changes are
typical of the microvascular involvement in systemic
sclerosis. Furthermore, quantitative and semi-qualitative
scoring is possible for these findings [6].
Usefulness of NVC for systemic sclerosis diagnosis
The 1980 ACR classification criteria [7, 8] for systemic
sclerosis lack sensitivity for the diagnosis of early sys-
temic sclerosis. The new classification criteria encom-
pass a broader spectrum of systemic sclerosis and focusFig. 1 Representation of the nailfold videocapillaroscopy analysis of
healthy donor. The vessels diameter is less than 20μm. Capillaries
form a straight line toward distal. The number of capillaries is more
than nine with in 1mm of the row of the nailfold bedon early diagnosis [1, 2]. Sensitivity and specificity for
the new classification criteria were 91 and 92 %, respect-
ively, while they were 75 and 72 %, respectively, for the
1980 ACR classification criteria. The new criteria include
“abnormal nailfold capillaries,” which are enlarged capil-
laries and/or capillary loss with or without pericapillary
hemorrhages at the nailfold (Fig. 2). Although capillaro-
scopy can be performed with highly specialized equip-
ment such as in videocapillaroscopy, dermatoscopes
(×30 magnifications) suffice for distinguishing between
normal and abnormal nailfold capillaries. Therefore,
there are no clear definitions of capillary thickness and
number for the criteria. However, it is desirable for phy-
sicians caring for systemic sclerosis patients to use
videocapillaroscopy (×200 magnifications) for an accur-
ate measurement of capillary fineness and number.
Qualitative and semi-quantitative scoring of
capillary
Although enlarged capillaries, capillary loss, and
pericapillary hemorrhages are included in the new
criteria, the severities of these findings are not men-
tioned. Qualitative and semi-quantitative scoring of
systemic sclerosis patterns by NVC has been intro-
duced recently and validated [6, 9].
The following capillaroscopic parameters were scored:
presence of enlarged and giant capillaries, hemorrhages,
loss of capillaries, disorganization of the microvascular
array, and capillary ramifications. The 6 parameters were
defined as follows [6]: (a) irregularly enlarged capillaries
(Fig. 3a) were defined as an increase in capillary diam-
eter (homogeneous or irregular) >20 μm; (b) giant capil-
laries (Fig. 3b) as homogeneously enlarged loops with a
diameter >50 μm; (c) microhemorrhages (Fig. 3c) as dark
masses due to hemosiderin deposits; (d) loss ofFig. 2 Representation of the nailfold videocapillaroscopy analysis of
patients with systemic sclerosis. Enlarged capillaries and pericapillary
hemorrhages at the nailfold are shown
Fig. 3 The six capillaroscopic parameters. a Irregularly enlarged capillary. b Giant capillary. c Micro hemorrhage. d Loss of capillaries. e Disorganization
of the microvascular array. f Capillary ramifications
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capillary numbers (the normal range was adopted from
literature; average 9 capillaries per linear mm at the dis-
tal row of the nailfold); (e) disorganization of the micro-
vascular array (Fig. 3e) seen as irregular capillary
distribution and orientation along with heterogeneity in
the loop shape; and (f ) capillary ramifications (Fig. 3f )
such as branching, bushy, or coiled capillaries that often
originated from a single normal sized capillary. Except
for irregularly enlarged capillaries, these parameters
characterize overt systemic sclerosis. Some habits such
as manicures, onychophagia, and guitar playing cause
microhemorrhages, which obviously do not depend on
any pathological condition. Hence, patients should re-
move nail polish 2 weeks before the examination.
Qualitative and semi-quantitative assessment can be
made by combining these findings. The NVC pattern is
classified into three different patterns, namely, early,
active, and late, which are clearly distinct from the normal
pattern (Table 1). The early pattern is characterized by few
giant capillaries, few capillary microhemorrhages, and no
evident loss of capillaries. The active pattern comprises
many giant capillaries, many capillary microhemorrhages,
and moderate loss of capillaries. The late pattern isTable 1 Nailfold videocapillaroscopy analysis of healthy donor
Early pattern Active pattern
Giant capillaries <33 % Giant capillaries >33 %
Capillary microhemorrhag
No loss of capillaries Loss of capillaries < 66 %
No disorganization of the capillary array Disorganization of the ca
No ramified capillaries Ramified capillaries <33 %characterized by irregular enlargement of capillaries, al-
most no giant capillaries and microhemorrhages, severe
loss of capillaries with extensive avascular areas, ramified
capillaries, and intense disorganization of the normal ca-
pillary array. The natural progression of microvascular
damage is from the early pattern to the late pattern
[10]. The presence of anti-Scl70 antibodies (also
called anti-topoisomerase I) seems to be related to
earlier expression of the active and late pattern. On
the other hand, anti-centromere antibody positivity
seems to be related to delayed expression of the late
NVC pattern [11].
A semi-quantitative rating scale (score 0–3) should be
adopted to score each of the aforementioned capillary
abnormalities (0 = no changes, 1 = less than 33 % capil-
lary alteration, 2 = 33–66 % capillary alteration, 3 =more
than 66 % capillary alteration, per linear mm). The mean
score value for each parameter should be calculated
from the analysis of at least 2 mm in the center of the
nailfold of each finger. The scores of irregularly enlarged
capillaries, giant capillaries, and microhemorrhages are
combined for the “A score.” Additionally, the scores for
the loss of capillaries, disorganization of the microvascu-
lar array, and capillary ramifications are combined forLate pattern
Giant capillaries <33 %
e >33 % Capillary microhemorrhage <33 %
Loss of capillaries >66 %
pillary array <66 % Disorganization of the capillary array >66 %
Ramified capillaries >66 %
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systemic sclerosis, while B score is higher in the late
phase. Interestingly, the A score decreases over time. In
contrast, the B score increases significantly during the
progression of microvascular damage [6]. We also ob-
served this trend in our systemic sclerosis cohort (n = 89),
and half of the patients showed progressive nailfold capil-
lary changes. Moreover, the progression of nailfold capil-
lary abnormalities in systemic sclerosis reflects organ
involvement.
The earliest stage of microangiopathy is characterized
by the appearance of giant capillaries. Concomitant
microhemorrhages arise as a consequence of damaged
microvessel walls. Subsequently, normally shaped capil-
laries progressively change, with all capillaries becoming
irregularly enlarged and evident loss of capillaries. In the
advanced stage of microangiopathy, both giant capillaries
and microhemorrhages disappear, and neoangiogenesis
with ramified capillaries induces microvascular array
disorganization.
Several methods such as the Steinbrocker method
(qualitative measure of radiographic damage) and the
Sharp method (semi-quantitative measure of radio-
graphic damage) have been introduced for scoring
plain radiographs in rheumatoid arthritis patients to
evaluate the disease course. Likewise, qualitative and
semi-quantitative scoring of capillaries will become
more important for the evaluation of the systemic
sclerosis disease course.
Clinical use of NVC
Multiple candidate therapies such as tocilizumab, rituxi-
mab, and autologous stem cell transplantation are being
clinically evaluated in systemic sclerosis patients. Espe-
cially, tocilizumab is expected to be useful for treating
systemic sclerosis. However, none of the targeted therap-
ies has become an established therapy. There are several
obstacles for clinical trials in systemic sclerosis. First,
there are no fully validated outcome measures. Second,
diagnosis of systemic sclerosis is often delayed and early
intervention is difficult. Moreover, systemic sclerosis has
clinical heterogeneity [12]. To date, early diagnosis of
systemic sclerosis can only be made using the new clas-
sification criteria. On the other hand, a lack of validated
outcome measures was identified in a systemic lupus er-
ythematosus clinical trial. Thus, it is important to have
validated outcome measures to obtain good clinical
evidence. For example, biological disease-modifying
anti-rheumatic drugs revolutionized the treatment of
rheumatoid arthritis patients. One of the reasons for
this revolution was that highly validated indices such
as the simplified disease activity index and 28-joint
disease activity scale were widely accepted worldwide
for objectively evaluating disease activity, and a lot ofclinical evidence was provided. As we have shown in
this paper, NVC is useful for both early diagnosis and
evaluation of disease progression. Scoring of capillary
abnormalities has become very important because
new treatments seem to be effective in modifying the
capillary bed morphology in systemic sclerosis patients.
Conclusions
Systemic sclerosis is a complex disease involving “auto-
immunity,” “inflammation,” “fibrosis,” and “vasculopa-
thy.” Therapeutic goals in systemic sclerosis include
minimization of damage from early inflammation and
autoimmunity, restoration of vascular homeostasis, pro-
motion of structural connective tissue repair, and reso-
lution of scarring [12]. As in other autoimmune diseases,
early diagnosis and intervention are important for achiev-
ing these goals. NVC has the potential to provide valuable
information for early diagnosis, disease activity, disease
progression, qualitative assessment, and pathogenesis of
systemic sclerosis. Further clinical application of NVC and
its epidemiology are required.
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